Epidemiologists have long suspected that a common virus may be a causative agent in Hodgkin's disease' and that the age of exposure to the virus may depend upon socioeconomic conditions.2 Recent studies have suggested a link between Epstein-Barr virus (EBV) and Hodgkin's disease in adults and children. [3] [4] [5] In previous studies we analysed the EBV status of malignant tissues from 74 British6 and 53 Kenyan7 children diagnosed with Hodgkin's disease. We used monoclonal antibodies specific for EBV latent membrane protein 1 (LMP 1),8 one of the key effectors of EBV induced cell transformation in vitro. 9 The results showed an almost complete concordance between EBV genome and LMP 1 presence in Reed-Stemnberg and Hodgkin's cells. However the EBV positivity rates varied significantly between the British children6 (50% of cases positive) and the Kenyan children7 (100% positive). In the present study we have analysed EBV status in childhood Hodgkin's disease using immunohistochemical staining for LMP 1. Some cases were further investigated using a sensitive in situ hybridisation for the EBV encoded small nuclear nonpolyadenylated RNAs (EBER-1), which are present at levels of 107 copies per cell in latently infected cells. ' One hundred and five cases from the United Kingdom, Egypt, Greece, South Africa, Australia, Costa Rica, and Kenya were tested with PCR to detect the presence of EB viral DNA and to determine the strain of the virus. In 59% EBV-1 alone was present, in 18% EBV-2 alone was found, and in 23% both virus strains were detected. The distribution of strain types varied between countries (table 5).
Discussion
Geographical or ethnic variation in the incidence of Hodgkin's disease is well described.20 21 The nature and pathogenesis of Hodgkin's disease is still an enigma and it is not clear whether it is a single entity or a syndrome. Recent studies on the pathogenesis in adults and children have associated it with EBV infection. Published data which used and cell survival in experimental systems in vitro30 and it is likely to be involved in the multistep oncogenic process in vivo. Nevertheless, despite the use of very sensitive techniques, EBV has not been found in a proportion of Hodgkin's disease cases. This has led to the hypothesis that an unknown cofactor is involved in the aetiology of Hodgkin's disease, but it is also possible that EBV negative cases are so diagnosed because of assay insensitivity. Our aims were to assess the possible role of EBV in the aetiology of Hodgkin's disease in children from different parts of the world. We analysed 277 biopsies from 10 countries with climates ranging from temperate to tropical and with varying socioeconomic conditions. In agreement with previous studies20 21 we found young age at diagnosis and mixed cellularity subtype were more common in children from developing countries. We note that the geographical distribution of strongly EBV related Hodgkin's disease appears to be very similar to that of EBV related Burkitt's lymphoma. While we showed a strong association between mixed cellularity subtype and EBV this did not account for the differences in LMP 1 positivity between countries.
Recent reports have described the prevalence of EBV strain type 2 In summary we found that EBV is actively involved in the pathogenesis of Hodgkin's disease in children, but the involvement varies according to the geographical and presumably the socioeconomic conditions. It is of interest that in Kenya all Hodgkin's disease cases had EBV and this resembles the situation in Burkitt's lymphoma.
We showed that dual infections can occur, and futher research is required to determine whether EBV is localised within specific cells. While infection with one strain of EBV might be expected to confer immunity to the other strain, our finding of dual infection in 21% of cases suggests that an underlying immune deficiency may contribute to the high levels of LMP 1 positivity seen particularly in Costa Rica and Kenya. 
